BANK VONTOBEL/CALL/ROCHE GS/260/0.1/20.12.24 Share Price

Warrant

DE000VM2JVC7

Market Closed - Deutsche Boerse AG 11:32:01 28/06/2024 pm IST
0.95 EUR -6.86% Intraday chart for BANK VONTOBEL/CALL/ROCHE GS/260/0.1/20.12.24
Current month+102.13%
1 month+120.93%
Date Price Change
28/24/28 0.95 -6.86%
27/24/27 1.02 +5.15%
26/24/26 0.97 -19.17%
25/24/25 1.2 +5.26%
24/24/24 1.14 +4.59%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 11:32 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WKN VM2JVC
ISINDE000VM2JVC7
Date issued 15/09/2023
Strike 260 CHF
Maturity 20/12/2024 (173 Days)
Parity 10 : 1
Emission price 2.07
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 1.99
Lowest since issue 0.23
Delta0.43x
Omega 10.75
Premium8.18x
Gearing25.16x
Moneyness 0.9596
Difference Strike 10.5 CHF
Difference Strike %+4.04%
Spread 0.14
Spread %12.73%
Intrinsic value 0.000000

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
249.5 CHF
Average target price
278.1 CHF
Spread / Average Target
+11.44%
Consensus